| 前收市價 | 33.39 |
| 開市 | 33.65 |
| 買盤 | 0.00 x 900 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 32.68 - 35.15 |
| 52 週波幅 | 16.45 - 62.21 |
| 成交量 | |
| 平均成交量 | 1,496,463 |
| 市值 | 3.073B |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -6.90 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 58.25 |
ZacksDown -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
Biohaven Ltd. (BHVN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksDown -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Biohaven Ltd. (BHVN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
InvestorPlace3 Biotech Stocks to Buy on the Dip: April 2024
If you follow Warren Buffett’s advice of being greedy when others are fearful, then it probably makes sense to consider biotech stocks to buy on the dip. Primarily, the thesis centers on the underlying necessity of the ecosystem. While humans have made incredible innovations in the digital realm, those don’t mean a whole lot if we succumb to various diseases and conditions. So, from the standpoint of social progress, the biotechnology sector is critical. Moreover, the industry may be somewhat in
